Related Experiment Video For diagnostic
Updated: Feb 25, 2026

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
Published on: November 7, 2025
The future: diagnostic and imaging advances in MEN1 therapeutic approaches and management strategies
Jerena Manoharan1, Max B Albers2, Detlef K Bartsch2
1Department of VisceralThoracic and Vascular Surgery, Philipps University Marburg, Marburg, Germany jerena.manoharan@uk-gm.de.
Abstract:
Prospective randomized data are lacking, but current clinical expert guidelines recommend annual screening examinations, including laboratory assessments and various imaging modalities (e.g. CT, MRI, scintigraphy and EUS) for patients with multiple endocrine neoplasia type 1 (MEN1). Routine screening is proposed to detect and localize neuroendocrine manifestations as early as possible. The goal is timely intervention to improve quality of life and to increase life expectancy by preventing the development of life-threatening hormonal syndromes and/or metastatic disease. In recent years, some studies compared different and new imaging methods regarding their sensitivity and utility in MEN1 patients. This present article reviews the proposed diagnostic tools for MEN1 screening as well as potential future perspectives.
Related Concept Videos
Urinary Tract Calculi III: Medical Management
Targeted Cancer Therapies
There are several types of targeted therapies against...
Imaging Studies IV: Magnetic Resonance Imaging
Chronic Pancreatitis II: Collaborative Care
Assessment:
Disorders of the Male Reproductive System
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
Nephrotic Syndrome II : Assessment and Medical Management

